Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.55NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BY.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.163NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22077.4South Korea
B.1.1.163NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.3 (Theta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.3 (Theta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.38.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAVNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.17 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.25.1.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.25.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.409NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.409NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.83NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.83NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.310NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.310NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.193NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-18487.6South Korea
B.1.1.193NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FP.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.84 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.84 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.99NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.99NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.343NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.343NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19749.2South Korea
A.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used